A Tetrahydrobiopterin Deficit Finding in Schizophrenia: A Confirmation Study
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.
Midhun T , Krishna S, Wilson S Neurochem Res. 2022; 47(5):1202-1211.
PMID: 35142994 DOI: 10.1007/s11064-022-03543-x.
References
1.
Clelland J, Read L, Smeed J, Clelland C
. Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders. Psychiatry Res. 2018; 262:229-236.
PMC: 5866784.
DOI: 10.1016/j.psychres.2018.02.020.
View
2.
Ota V, Noto C, Gadelha A, Santoro M, Spindola L, Gouvea E
. Changes in gene expression and methylation in the blood of patients with first-episode psychosis. Schizophr Res. 2014; 159(2-3):358-64.
DOI: 10.1016/j.schres.2014.09.008.
View
3.
Richardson M, Read L, Reilly M, Clelland J, Clelland C
. Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder. Neurochem Res. 2006; 32(1):107-13.
DOI: 10.1007/s11064-006-9233-5.
View
4.
Okusaga O
. 6R-l-erythro-5,6,7,8-tetrahydrobiopterin (BH4): a potential treatment for all symptom domains of schizophrenia. Med Hypotheses. 2014; 82(3):395-7.
DOI: 10.1016/j.mehy.2014.01.011.
View
5.
Morrison P, Murray R
. The antipsychotic landscape: dopamine and beyond. Ther Adv Psychopharmacol. 2018; 8(4):127-135.
PMC: 5846922.
DOI: 10.1177/2045125317752915.
View